×

Valeant CEO: Will not overbid for Allergan

12:05 PM ET Wed, 28 May 2014

Valeant Pharma CEO J. Michael Pearson, says his company will be persistent and patient with its bid for Allergan, but will not sacrifice running its business. Pearson discusses